Watch CLS. Know when insiders buy.
One email the day a filing lands. Free.
CLS
CELESTICA INC
304.61
+4.92 +1.64%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
30
FLAG · insiders 25, shorts 35
Insiders, 90 days
−$15.8M
net selling · 0 buys, 9 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
5 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $35BP/E 31.7DIV YIELD —FCF YIELD 1.48%REV TTM $15.6B +47.3%NET INCOME $1.1B +107.4%NET DEBT $248.3M52W 249.52 – 472.40SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $4.7B | +62.4% | 12.3% | $458.3M | $368.8M | +74.8% | 3.17 | $410.9M | $263.8M | $147.1M | Jul 27 |
| Q1 2026 · Mar 31 | $4B | +52.8% | 10.8% | $272.1M | $212.3M | +146.3% | 1.83 | $356.3M | $229.5M | $126.8M | Apr 27 |
| Q4 2025 · Dec 31derived | $3.7B | +43.6% | 11.8% | $314.4M | $267.5M | +76.3% | 2.30 | $250.6M | $94.7M | $155.9M | Feb 27 |
| Q3 2025 · Sep 30 | $3.2B | +27.8% | 13.0% | $325M | $267.8M | +199.2% | 2.31 | $126.2M | $37.3M | $88.9M | Oct 27 |
| Q2 2025 · Jun 30 | $2.9B | +21.0% | 12.8% | $272.5M | $211M | +122.1% | 1.82 | $152.4M | $32.5M | $119.9M | Jul 27 |
| Q1 2025 · Mar 31 | $2.6B | +19.9% | 10.3% | $128.8M | $86.2M | −6.1% | 0.74 | $130.3M | $36.7M | $93.6M | Apr 27 |
| Q4 2024 · Dec 31derived | $2.5B | — | 11.7% | $202.6M | $151.7M | — | 1.29 | $143.4M | $47.6M | $95.8M | Feb 27 |
| Q3 2024 · Sep 30 | $2.5B | — | 10.4% | $138M | $89.5M | — | 0.75 | $122.8M | $46M | $76.8M | Oct 27 |
| Q2 2024 · Jun 30 | $2.4B | — | 10.6% | $132.9M | $95M | — | 0.80 | $99.6M | $36.9M | $62.7M | Jul 28 |
| Q1 2024 · Mar 31 | $2.2B | — | 10.1% | $125.8M | $91.8M | — | 0.77 | $108.1M | $40.4M | $67.7M | Apr 24 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $12.4B | 12.1% | $1B | $832.5M | 6.7% | 7.16 | $659.5M | $201.2M | $458.3M | $153.4M | — |
| FY2024 · to Dec 31 | $9.6B | 10.7% | $599.3M | $428M | 4.4% | 3.61 | $473.9M | $170.9M | $303M | $152M | — |
| FY2023 · to Dec 31 | $8B | 9.5% | $338.3M | $244.4M | 3.1% | 2.03 | $326.2M | $125.1M | $201.1M | $35.6M | — |
| FY2022 · to Dec 31 | $7.3B | 9.0% | $289.3M | $180.1M | 2.5% | 1.46 | $211.1M | $109M | $102.1M | $34.6M | — |
Every number comes from CELESTICA INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.